Literature DB >> 8285754

Growth retardation after dexamethasone administration: assessment by knemometry.

A T Gibson1, R G Pearse, J K Wales.   

Abstract

Knemometry has been used to measure lower leg growth during 32 nine day courses of dexamethasone in 26 babies ranging from 24 to 32 weeks' gestation at birth. Mean leg length velocity was 0.37 mm/day in the 10 days before steroids. Administration of dexamethasone was associated with a decrease in velocity in all babies, and in 15 leg shortening was documented. Mean leg length velocity during steroid treatment was -0.003 mm/day. After the course of dexamethasone was completed there was an immediate increase in leg length velocity to a mean of 0.52 mm/day over the first 10 days then falling to a value similar to the growth velocity observed before treatment. Leg length had reached the value predicted by growth before steroids about 30 days after dexamethasone. The reduction in leg length velocity occurred despite a significant increase in energy intake and decrease in oxygen requirements.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8285754      PMCID: PMC1029593          DOI: 10.1136/adc.69.5_spec_no.505

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  35 in total

1.  Inhibition of growth and other effects of ACTH in premature infants.

Authors:  W A SILVERMAN; R L DAY; F C BLODI
Journal:  Pediatrics       Date:  1951-08       Impact factor: 7.124

2.  Knemometry in assessment of linear growth.

Authors:  J K Wales; R D Milner
Journal:  Arch Dis Child       Date:  1987-02       Impact factor: 3.791

3.  Oxygen consumption in infants with bronchopulmonary dysplasia.

Authors:  M R Weinstein; W Oh
Journal:  J Pediatr       Date:  1981-12       Impact factor: 4.406

4.  Accurate measurements of the lower leg length and the ulnar length and its application in short term growth measurement.

Authors:  I M Valk; A M Chabloz; A G Smals; P W Kloppenborg; F G Cassorla; E A Schutte
Journal:  Growth       Date:  1983

5.  Growth spurts in transplanted rat humeri in adult hosts.

Authors:  E M Harkness
Journal:  Prog Clin Biol Res       Date:  1982

6.  Long-term morbidity of infants with bronchopulmonary dysplasia.

Authors:  R S Sauve; N Singhal
Journal:  Pediatrics       Date:  1985-11       Impact factor: 7.124

Review 7.  Complications of corticosteroid therapy.

Authors:  M E Rimsza
Journal:  Am J Dis Child       Date:  1978-08

8.  Steroid and growth hormone levels in premature infants after prenatal betamethasone therapy to prevent respiratory distress syndrome.

Authors:  P L Ballard; P D Gluckman; G C Liggins; S L Kaplan; M M Grumbach
Journal:  Pediatr Res       Date:  1980-02       Impact factor: 3.756

9.  Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia.

Authors:  M C Mammel; T P Green; D E Johnson; T R Thompson
Journal:  Lancet       Date:  1983-06-18       Impact factor: 79.321

10.  Glucocorticoid effects on somatomedins and somatomedin inhibitors.

Authors:  T G Unterman; L S Phillips
Journal:  J Clin Endocrinol Metab       Date:  1985-10       Impact factor: 5.958

View more
  18 in total

1.  Knee-heel length measurement in healthy preterm infants.

Authors:  I J Griffin; N M Pang; J Perring; R J Cooke
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-07       Impact factor: 5.747

Review 2.  Antenatal treatment of a mother bearing a fetus with congenital adrenal hyperplasia.

Authors:  C G Brook
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-05       Impact factor: 5.747

Review 3.  A risk-benefit assessment of drugs used for neonatal chronic lung disease.

Authors:  D G Sweet; H L Halliday
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

4.  The EPICure study: growth and associated problems in children born at 25 weeks of gestational age or less.

Authors:  N S Wood; K Costeloe; A T Gibson; E M Hennessy; N Marlow; A R Wilkinson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-11       Impact factor: 5.747

5.  Growth effects of systemic versus inhaled steroids in chronic lung disease.

Authors:  R M Nicholl; A Greenough; M King; P Cheeseman; H R Gamsu
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-07       Impact factor: 5.747

6.  Feeding premature infants after hospital discharge.

Authors:  D E Yuen
Journal:  Paediatr Child Health       Date:  1998-09       Impact factor: 2.253

7.  Short-term growth: rhythms, chaos, or noise?

Authors:  J K Wales; A T Gibson
Journal:  Arch Dis Child       Date:  1994-07       Impact factor: 3.791

8.  Risk factors and correlates of neonatal growth velocity in extremely low gestational age newborns: the ELGAN Study.

Authors:  Julie Bartholomew; Camilia R Martin; Elizabeth Allred; Minghua L Chen; Richard A Ehrenkranz; Olaf Dammann; Alan Leviton
Journal:  Neonatology       Date:  2013-10-30       Impact factor: 4.035

Review 9.  Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.

Authors:  Lex W Doyle; Jeanie L Cheong; Richard A Ehrenkranz; Henry L Halliday
Journal:  Cochrane Database Syst Rev       Date:  2017-10-24

10.  Improved weight attainment of extremely low-gestational-age infants with bronchopulmonary dysplasia.

Authors:  J Madden; K Kobaly; N M Minich; M Schluchter; D Wilson-Costello; M Hack
Journal:  J Perinatol       Date:  2009-10-01       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.